FDA accepts Merck’s NDA for doravirine/islatravir...
Category : Clinical Trial Update 11 July 2025Overview Merck, known as MSD outside of the United States and Canada, announced that the US Food...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Verified Clinical Trials starts in Japan with MRJ...
Category : Clinical Trial Update 11 July 2025Overview Verified Clinical Trials, a global leader in clinical trial subject registry solutions,...
MapLight initiates phase 2 ZEPHYR study of ML-007C...
Category : Clinical Trial Update 11 July 2025Overview MapLight Therapeutics, a clinical-stage biopharmaceutical company focused on improving t...
REGENXBIO Reports Preclinical Benefits of RGX-202...
Category : Clinical Trial Update 11 July 2025REGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Mi...
BlueRock announces first patient receives investig...
Category : Clinical Trial Update 10 July 2025Overview Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly...
Latest Newsletter Post
-
REGENXBIO Reports Preclinical Benef..
11 July 2025
-
MapLight initiates phase 2 ZEPHYR s..
11 July 2025
-
Verified Clinical Trials starts in..
11 July 2025
-
FDA accepts Merck’s NDA for doravir..
11 July 2025
-
Zhimeng Biopharma’s KCNQ2/3 Opener..
10 July 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com